Clinical Research & Reference Standard Compendium
Tesamorelin + Ipamorelin Spray - Scientific Literature
I. Abstract & Overview
Tesamorelin + Ipamorelin is a two-component research blend that engages the growth hormone axis at two independent points. Tesamorelin is a stabilized 44-residue analog of growth hormone-releasing hormone, carrying a short acyl group on its N-terminal tyrosine that blocks the aminopeptidase cleavage limiting the native hormone. Ipamorelin is a 5-residue ghrelin receptor agonist first described by Raun and colleagues in 1998, notable because it released growth hormone in laboratory models without the cortisol and prolactin elevation characteristic of earlier secretagogues such as GHRP-6. Because the two act on different receptors coupled to different G proteins, the pairing allows a single preparation to raise both cAMP and intracellular calcium in somatotroph models. Research Use Only (RUO).
II. Chemical Specifications
| Molecular Formula | Blend — Tesamorelin C221H366N72O67S and Ipamorelin C38H49N9O5; no single formula applies |
|---|---|
| Molar Mass | Tesamorelin 5135.9 g/mol; Ipamorelin 711.9 g/mol — confirm the blend ratio with manufacturer COA |
| CAS Registry Number | N/A |
| Amino Acid Sequence | Two-peptide blend: Tesamorelin, a 44-residue acylated GHRH analog, combined with Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2, 5 residues) — verify ratio with manufacturer COA |
III. Mechanism & Cellular Signaling Pathways
The two components of this blend converge on growth hormone release from opposite directions. Tesamorelin activates the GHRH receptor, a class B G protein-coupled receptor on pituitary somatotroph cells, which couples through adenylyl cyclase to raise cAMP and activate protein kinase A. Phosphorylated CREB then drives Pit-1 expression, sustaining transcription of the growth hormone gene, so this arm increases synthesis as well as release. Ipamorelin activates the ghrelin receptor, which couples instead through phospholipase C, generating inositol trisphosphate and releasing calcium from intracellular stores to trigger vesicle fusion. Research shows Ipamorelin also reduces somatostatin tone, removing an inhibitory brake. The pairing is mechanistically distinct from combining two GHRH analogs, since those would compete for the same receptor rather than complement one another.
IV. Primary Research Directions
- **Dual Pathway Pharmacology:** Research shows simultaneous engagement of the GHRH receptor and the ghrelin receptor, allowing cAMP and intracellular calcium to be tracked in the same somatotroph preparation.
- **Additive Versus Synergistic Testing:** Laboratory investigations run each component alone in adjacent wells to establish whether the combined growth hormone response exceeds the sum of the parts.
- **Secretagogue Selectivity:** Raun and colleagues (1998) report that Ipamorelin releases growth hormone without the cortisol and prolactin response seen with GHRP-6, making it the clean comparator in selectivity panels.
- **Growth Hormone Release Assays:** Studies indicate increased growth hormone secretion into culture medium, quantified by immunoassay in primary rat pituitary cell preparations.
- **Somatostatin Tone Studies:** Research shows the ghrelin receptor arm reduces inhibitory somatostatin signaling, a variable that can be isolated by comparing blend and single-component responses.
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Ferdinandi, E. S., Brazeau, P., High, K., et al. (2007). 'Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.' Basic & Clinical Pharmacology & Toxicology, 100(1), 49-58. DOI: 10.1111/j.1742-7843.2007.00008.x | PMID: 17214611
- Raun, K., Hansen, B. S., Johansen, N. L., et al. (1998). 'Ipamorelin, the first selective growth hormone secretagogue.' European Journal of Endocrinology, 139(5), 552-561. DOI: 10.1530/eje.0.1390552 | PMID: 9849822
- Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Tesamorelin + Ipamorelin Spray
Abstract & Overview
Tesamorelin + Ipamorelin is a two-component research blend that engages the growth hormone axis at two independent points. Tesamorelin is a stabilized 44-residue analog of growth hormone-releasing hormone, carrying a short acyl group on its N-terminal tyrosine that blocks the aminopeptidase cleavage limiting the native hormone. Ipamorelin is a 5-residue ghrelin receptor agonist first described by Raun and colleagues in 1998, notable because it released growth hormone in laboratory models without the cortisol and prolactin elevation characteristic of earlier secretagogues such as GHRP-6. Because the two act on different receptors coupled to different G proteins, the pairing allows a single preparation to raise both cAMP and intracellular calcium in somatotroph models. Research Use Only (RUO).
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Tesamorelin + Ipamorelin Spray) | 9.40 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 9.40 minutes represents the active compound (Tesamorelin + Ipamorelin Spray). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
The two components of this blend converge on growth hormone release from opposite directions. Tesamorelin activates the GHRH receptor, a class B G protein-coupled receptor on pituitary somatotroph cells, which couples through adenylyl cyclase to raise cAMP and activate protein kinase A. Phosphorylated CREB then drives Pit-1 expression, sustaining transcription of the growth hormone gene, so this arm increases synthesis as well as release. Ipamorelin activates the ghrelin receptor, which couples instead through phospholipase C, generating inositol trisphosphate and releasing calcium from intracellular stores to trigger vesicle fusion. Research shows Ipamorelin also reduces somatostatin tone, removing an inhibitory brake. The pairing is mechanistically distinct from combining two GHRH analogs, since those would compete for the same receptor rather than complement one another.
Primary Research Directions
**Dual Pathway Pharmacology:** Research shows simultaneous engagement of the GHRH receptor and the ghrelin receptor, allowing cAMP and intracellular calcium to be tracked in the same somatotroph preparation.
**Additive Versus Synergistic Testing:** Laboratory investigations run each component alone in adjacent wells to establish whether the combined growth hormone response exceeds the sum of the parts.
**Secretagogue Selectivity:** Raun and colleagues (1998) report that Ipamorelin releases growth hormone without the cortisol and prolactin response seen with GHRP-6, making it the clean comparator in selectivity panels.
**Growth Hormone Release Assays:** Studies indicate increased growth hormone secretion into culture medium, quantified by immunoassay in primary rat pituitary cell preparations.
**Somatostatin Tone Studies:** Research shows the ghrelin receptor arm reduces inhibitory somatostatin signaling, a variable that can be isolated by comparing blend and single-component responses.
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Ferdinandi, E. S., Brazeau, P., High, K., et al. (2007). 'Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.' Basic & Clinical Pharmacology & Toxicology, 100(1), 49-58. DOI: 10.1111/j.1742-7843.2007.00008.x | PMID: 17214611
Raun, K., Hansen, B. S., Johansen, N. L., et al. (1998). 'Ipamorelin, the first selective growth hormone secretagogue.' European Journal of Endocrinology, 139(5), 552-561. DOI: 10.1530/eje.0.1390552 | PMID: 9849822
Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
